These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38505146)

  • 1. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
    Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
    Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
    Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
    J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
    [No Abstract]   [Full Text] [Related]  

  • 4. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
    Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
    Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
    J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.
    Fukushima N; Masuda T; Tsuboi K; Takahashi K; Yuda M; Fujisaki M; Ikegami T; Yano F; Eto K
    Surg Today; 2024 Mar; ():. PubMed ID: 38491233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.
    Zhang J; Zhao Q; Liu S; Yuan N; Hu Z
    Front Public Health; 2024; 12():1395134. PubMed ID: 38841671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
    Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
    Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
    Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
    Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
    Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
    HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery.
    Feng J; Wang L; Yang X; Chen Q
    Sci Rep; 2024 Jan; 14(1):713. PubMed ID: 38184747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
    Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
    In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
    Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
    Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
    Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.